ES517022A0 - Procedimiento de preparar compuestos 1,4-dihidropiridinicos. - Google Patents

Procedimiento de preparar compuestos 1,4-dihidropiridinicos.

Info

Publication number
ES517022A0
ES517022A0 ES517022A ES517022A ES517022A0 ES 517022 A0 ES517022 A0 ES 517022A0 ES 517022 A ES517022 A ES 517022A ES 517022 A ES517022 A ES 517022A ES 517022 A0 ES517022 A0 ES 517022A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
dihydropyridine compounds
dihydropyridine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES517022A
Other languages
English (en)
Other versions
ES8406439A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruko Pharmaceutical Co Ltd
Original Assignee
Maruko Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16696381A external-priority patent/JPS5867668A/ja
Priority claimed from JP259782A external-priority patent/JPS58121288A/ja
Priority claimed from JP2839182A external-priority patent/JPS58146565A/ja
Application filed by Maruko Pharmaceutical Co Ltd filed Critical Maruko Pharmaceutical Co Ltd
Publication of ES517022A0 publication Critical patent/ES517022A0/es
Publication of ES8406439A1 publication Critical patent/ES8406439A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES517022A 1981-10-19 1982-10-19 Procedimiento de preparar compuestos 1,4-dihidropiridinicos. Expired ES8406439A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16696381A JPS5867668A (ja) 1981-10-19 1981-10-19 1,4−ジヒドロピリジン誘導体
JP259782A JPS58121288A (ja) 1982-01-11 1982-01-11 1,4−ジヒドロピリジン誘導体
JP2839182A JPS58146565A (ja) 1982-02-24 1982-02-24 1,4−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
ES517022A0 true ES517022A0 (es) 1984-08-16
ES8406439A1 ES8406439A1 (es) 1984-08-16

Family

ID=27275435

Family Applications (2)

Application Number Title Priority Date Filing Date
ES517022A Expired ES8406439A1 (es) 1981-10-19 1982-10-19 Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
ES527980A Granted ES527980A0 (es) 1981-10-19 1983-11-30 Procedimiento de preparar compuestos 1,4-dihidropiridinicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES527980A Granted ES527980A0 (es) 1981-10-19 1983-11-30 Procedimiento de preparar compuestos 1,4-dihidropiridinicos.

Country Status (12)

Country Link
US (1) US4446325A (es)
KR (1) KR880002704B1 (es)
AU (1) AU555036B2 (es)
CA (1) CA1177079A (es)
CH (1) CH650498A5 (es)
DE (1) DE3238705A1 (es)
ES (2) ES8406439A1 (es)
FR (1) FR2514761B1 (es)
GB (1) GB2111978B (es)
IT (1) IT1189393B (es)
NL (1) NL194203C (es)
SE (1) SE442864B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
DE3514865A1 (de) * 1985-04-25 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
ES2040697T3 (es) * 1986-12-18 1993-11-01 Kurt H. Prof. Dr. Bauer Concentrado de nifedipina estabilizado frente a la influencia de la luz, y procedimiento para su preparacion.
DE60128683T2 (de) * 2000-04-11 2008-01-24 Sankyo Co., Ltd. Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
KR20070054644A (ko) * 2004-07-26 2007-05-29 액테리온 파마슈티칼 리미티드 미립자 제형으로 흡입된 일로프로스트에 의한 폐고혈압의치료
ATE551059T1 (de) 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CN103906508A (zh) 2011-08-26 2014-07-02 沃克哈特有限公司 治疗心血管疾病的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
ES8504127A1 (es) 1985-04-16
ES527980A0 (es) 1985-04-16
CA1177079A (en) 1984-10-30
NL8204014A (nl) 1983-05-16
KR840001954A (ko) 1984-06-07
SE8205905L (sv) 1983-04-20
GB2111978B (en) 1985-05-01
AU8931782A (en) 1983-04-28
DE3238705A1 (de) 1983-07-14
ES8406439A1 (es) 1984-08-16
AU555036B2 (en) 1986-09-11
DE3238705C2 (es) 1989-11-09
IT1189393B (it) 1988-02-04
SE8205905D0 (sv) 1982-10-18
FR2514761B1 (fr) 1985-09-06
US4446325A (en) 1984-05-01
CH650498A5 (de) 1985-07-31
NL194203C (nl) 2001-09-04
KR880002704B1 (ko) 1988-12-26
SE442864B (sv) 1986-02-03
IT8249295A0 (it) 1982-10-18
FR2514761A1 (fr) 1983-04-22
NL194203B (nl) 2001-05-01
GB2111978A (en) 1983-07-13

Similar Documents

Publication Publication Date Title
ES543653A0 (es) Procedimiento de preparar derivados de 1,4-dihidropiridinas
DK159442C (da) Analogifremgangsmaade til fremstilling af 6,7-substitueret-4-ethyl-quinazoliner
ES520638A0 (es) Procedimiento de preparar compuestos carbostirilicos.
ES507493A0 (es) Procedimiento de preparar compuestos benzoheterociclicos.
ES516275A0 (es) Procedimiento para preparar 1,2-dihidroxi-ciclohexadienos.
NO820795L (no) Fremgangsmaate for mikroinnkapsling.
ES507545A0 (es) Procedimiento de preparar compuestos carbostirilicos.
ES537269A0 (es) Un procedimiento para la prpeparacion de compuestos de 1,4-dihidropiridina.
DE3382204D1 (de) 1,4-dihydropyridin-derivate.
ES517022A0 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
FI853255L (fi) Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.
NO880473D0 (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner.
DK157855C (da) Fremgangsmaade til fremstilling af 2,3-dichlor-5-trichlormethylpyridin
DK160489C (da) Fremgangsmaade til fremstilling af 2,3-difluorpyridinforbindelser
ES523243A0 (es) "procedimiento para preparar derivados de 1,4-dihidropiridina".
DK113483A (da) Fremgangsmaade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
DK153488C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydro-4h-thieno(3,2-c-)-pyridin-2-onderivater
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.
FI834289A (fi) Medbringare foer en draganordning.
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
FI821046A0 (fi) Foerfarande foer framstaellning av -(3,4,5-trimetoxibenzoyltio)-propionylglycin
ES512194A0 (es) "procedimiento de preparar compuestos piridotienopiridacinicos".
ES533691A0 (es) Procedimiento de preparar 2,9-dihidrofuranos
NO872624D0 (no) Fremgangsmaate for fremstilling av 3,7-dihydro-3-n-propyl-1h-purin-2,6-dion.